Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""RED CELL"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 10132
Tytuł:
HLA-B*46:01:01:01 and HLA-DRB1*09:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia.
Autorzy:
Suttichet TB; Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Chamnanphon M; Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pongpanich M; Department of Mathematics and Computer Science, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.; Faculty of Science, Omics Sciences and Bioinformatics Center, Chulalongkorn University, Bangkok, Thailand.
Chokyakorn S; Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Kupatawintu P; National Blood Center, Thai Red Cross Society, Bangkok, Thailand.
Srichomthong C; Department of Pediatrics, Faculty of Medicine, Center of Excellence for Medical Genomics, Chulalongkorn University, Bangkok, Thailand.; Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Chetruengchai W; Department of Pediatrics, Faculty of Medicine, Center of Excellence for Medical Genomics, Chulalongkorn University, Bangkok, Thailand.; Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Chuntakaruk H; Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand.; Department of Biochemistry, Faculty of Science, Center of Excellence in Structural and Computational Biology, Chulalongkorn University, Bangkok, Thailand.
Rungrotmongkol T; Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok, Thailand.; Department of Biochemistry, Faculty of Science, Center of Excellence in Structural and Computational Biology, Chulalongkorn University, Bangkok, Thailand.
Chariyavilaskul P; Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. .; Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. .
Shotelersuk V; Department of Pediatrics, Faculty of Medicine, Center of Excellence for Medical Genomics, Chulalongkorn University, Bangkok, Thailand.; Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Praditpornsilpa K; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 20; Vol. 13 (1), pp. 22759. Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:
Journal Article
MeSH Terms:
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/genetics
Erythropoietin*
Renal Insufficiency, Chronic*/chemically induced
Humans ; Case-Control Studies ; HLA-B Antigens/genetics ; Recombinant Proteins/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma.
Autorzy:
Rueda Prada L; Mayo Clinic College of Medicine and Science, Rochester, MN, USA.; Department of Hospital Medicine, Mayo Clinic, Jacksonville, FL, USA.
Gavrancic T; Mayo Clinic College of Medicine and Science, Rochester, MN, USA.; Department of Hospital Medicine, Mayo Clinic, Jacksonville, FL, USA.
Cadena Sanabria MO; Department of Internal Medicine, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia.
Dumic I; Mayo Clinic College of Medicine and Science, Rochester, MN, USA.; Department of Hospital Medicine, Mayo Clinic Health System, Eau Claire, FL, USA.
Bourgeois K; Department of Pathology, Mayo Clinic, Jacksonville, FL, USA.
King RL; Division of Hemopathology, Mayo Clinic, Rochester, MN, USA.
Yan Y; Mayo Clinic College of Medicine and Science, Rochester, MN, USA.; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Nov 14; Vol. 24, pp. e941789. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Melanoma*/drug therapy
Red-Cell Aplasia, Pure*/chemically induced
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/diagnosis
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Nivolumab/adverse effects ; Steroids/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report.
Autorzy:
Kumar V; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC, 27599-7305, USA.
Montgomery ND; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
van Deventer HW; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Whang YE; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC, 27599-7305, USA. .; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 May 28; Vol. 17 (1), pp. 220. Date of Electronic Publication: 2023 May 28.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/drug therapy
Red-Cell Aplasia, Pure*/chemically induced
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/complications
Anemia*/chemically induced
Prostatic Neoplasms*/complications
Lymphoproliferative Disorders*
Humans ; Male ; Aged ; Immune Checkpoint Inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.
Autorzy:
Park S; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Yun J; Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Choi SY; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jeong D; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Gu JY; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Lee JS; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Seong MW; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Chang YH; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Yun H; Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea. .
Kim HK; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. .; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 04; Vol. 13 (1), pp. 7280. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Large Granular Lymphocytic*/genetics
Red-Cell Aplasia, Pure*/genetics
Red-Cell Aplasia, Pure*/drug therapy
Anemia*/complications
Myelodysplastic Syndromes*
Humans ; Retrospective Studies ; Mutation ; STAT3 Transcription Factor/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A pregnant woman with thymoma-associated pure red cell aplasia.
Autorzy:
Shibata M; Division of Obstetrics, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
Kaneko K; Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan. .
Umehara N; Division of Obstetrics, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
Matsui H; Division of Obstetrics, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
Kawai T; Division of Immunology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
Nakadate H; Division of Hematology, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
Murashimia A; Division of Maternal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
Sago H; Division of Obstetrics, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-Ku, Tokyo, Japan.
Pokaż więcej
Źródło:
BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2022 Oct 27; Vol. 22 (1), pp. 795. Date of Electronic Publication: 2022 Oct 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Thymoma*/complications
Thymoma*/diagnostic imaging
Thymoma*/surgery
Thymus Neoplasms*/complications
Thymus Neoplasms*/diagnosis
Thymus Neoplasms*/surgery
Red-Cell Aplasia, Pure*/complications
Red-Cell Aplasia, Pure*/pathology
Female ; Humans ; Pregnancy ; Infant, Newborn ; Adult ; Cyclosporine ; Pregnant Women ; Placenta/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acquired pure red cell aplasia after severe acute respiratory syndrome corona virus 2 infection: a case report.
Autorzy:
Karrat I; Sidi Mohamed Ben Abdellah University, Faculty of Medicine and Pharmacy, Fez, Morocco. .; Department of Clinical Haematology, Moulay Ismail Military Teaching Hospital, Meknes, Morocco. .; University Hospital Center Hassan II, Fez, Morocco. .
Eddou H; Sidi Mohamed Ben Abdellah University, Faculty of Medicine and Pharmacy, Fez, Morocco.; Department of Clinical Haematology, Moulay Ismail Military Teaching Hospital, Meknes, Morocco.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2022 Oct 19; Vol. 16 (1), pp. 375. Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
COVID-19*/complications
Red-Cell Aplasia, Pure*/complications
Red-Cell Aplasia, Pure*/therapy
Male ; Humans ; Aged ; Pandemics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[ABO incompatibility and complications in hematopoietic stem cell transplantation].
Autorzy:
Jiménez-Ochoa MA; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Unidad de Trasplante de Médula Ósea. Ciudad de México, México.
Contreras-Serratos MM; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Unidad de Trasplante de Médula Ósea. Ciudad de México, México.
González-Bautista ML; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Unidad de Trasplante de Médula Ósea. Ciudad de México, México.
López-Macías C; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Unidad de Investigación Médica en Inmunoquímica. Ciudad de México, México.
Torres-Fierro A; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Unidad de Trasplante de Médula Ósea. Ciudad de México, México.
Urbina-Escalante E; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades 'Dr. Bernardo Sepúlveda Gutiérrez', Unidad de Trasplante de Médula Ósea. Ciudad de México, México.
Pokaż więcej
Transliterated Title:
Incompatibilidad ABO en el trasplante de células progenitoras hematopoyéticas y sus complicaciones.
Źródło:
Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2023 Jan 01; Vol. 61 (Suppl 1), pp. S12-S18. Date of Electronic Publication: 2023 Jan 01.
Typ publikacji:
Observational Study; English Abstract; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Red-Cell Aplasia, Pure*/etiology
Humans ; Blood Group Incompatibility/etiology ; Transplantation, Homologous/adverse effects ; Retrospective Studies ; ABO Blood-Group System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Thymic hyperplasia as a rare etiology of pure red cell aplasia.
Autorzy:
Arsenović, Isidora
Leković, Danijela
Šefer, Dijana
Ivanović, Jelena
Smiljanić, Mihajlo
Bogdanović, Andrija
Pokaż więcej
Alternatywny tytuł:
Hiperplazija timusa kao retka etiologija čiste aplazije eritroidne loze.
Źródło:
Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia. 2024, Vol. 81 Issue 1, p56-60. 5p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Anti-AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia.
Autorzy:
Yong J; Department of Haemato-oncology, Clatterbridge Cancer Centre, Liverpool, UK.; Department of Haematology, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK.
Johnstone M; Department of Haemato-oncology, Clatterbridge Cancer Centre, Liverpool, UK.; Department of Haematology, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK.
Callaghan T; NHS Blood and Transplant, Liverpool, UK.
Chandrasekar A; NHS Blood and Transplant, Liverpool, UK.
Pervaiz MS; Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Pokaż więcej
Źródło:
Transfusion medicine (Oxford, England) [Transfus Med] 2022 Aug; Vol. 32 (4), pp. 346-348. Date of Electronic Publication: 2022 May 25.
Typ publikacji:
Letter
MeSH Terms:
Red-Cell Aplasia, Pure*/therapy
Transfusion Reaction*
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Isolated Anemia in a 69-Year-Old Man with HIV-1: Features of Pure Red Cell Aplasia Mediated by Chronic Parvovirus-B19 Infection.
Autorzy:
Wylde J; Department of General Medicine, Joondalup Health Campus, Joondalup, Western Australia, Australia.
Berneri MA; Department of General Medicine, Joondalup Health Campus, Joondalup, Western Australia, Australia.
Malherbe JAJ; Department of General Medicine, Joondalup Health Campus, Joondalup, Western Australia, Australia.; Medical School, University of Western Australia, Crawley, Western Australia, Australia.
Davel S; Department of General Medicine, Joondalup Health Campus, Joondalup, Western Australia, Australia.; Medical School, University of Western Australia, Crawley, Western Australia, Australia.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 Jul 25; Vol. 23, pp. e936445. Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Acquired Immunodeficiency Syndrome*/complications
Anemia*/etiology
Graft vs Host Disease*/complications
HIV Infections*/complications
HIV Infections*/drug therapy
HIV-1*
Parvoviridae Infections*/complications
Parvoviridae Infections*/diagnosis
Parvovirus*
Parvovirus B19, Human*
Red-Cell Aplasia, Pure*/diagnosis
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/etiology
Aged ; Australia ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.
Autorzy:
Kitpermkiat R; Division of Nephrology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Thotsiri S; Division of Nephrology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Arpornsujaritkun N; Division of Vascular and Transplantation Surgery, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Sangkum P; Division of Urology, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Chantrathammachart P; Division of Hematology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Kitpoka P; Department of Pathology, Faculty of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Thammanichanond D; Department of Pathology, Faculty of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Virankabutra T; Department of Anesthesiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Kantachuvesiri S; Division of Nephrology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 Jul 17; Vol. 23, pp. e935451. Date of Electronic Publication: 2022 Jul 17.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Erythropoietin*/therapeutic use
Kidney Failure, Chronic*/complications
Kidney Failure, Chronic*/therapy
Kidney Transplantation*/methods
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/etiology
ABO Blood-Group System ; Blood Group Incompatibility ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Prednisolone ; Renal Dialysis ; Tacrolimus/therapeutic use ; Thailand
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Erythroblastopenia and primary myelofibrosis: a very rare association (a case report)].
Autorzy:
El Maachi N; Service d'Hématologie Clinique, Hôpital Militaire d´Instruction Mohamed V, Rabat, Maroc.
El Mehdi M; Service d'Hématologie Clinique, Hôpital Militaire d´Instruction Mohamed V, Rabat, Maroc.
Filali IA; Service d'Hématologie Clinique, Hôpital Militaire d´Instruction Mohamed V, Rabat, Maroc.
Jennane S; Service d'Hématologie Clinique, Hôpital Militaire d´Instruction Mohamed V, Rabat, Maroc.
El Maaroufi H; Service d'Hématologie Clinique, Hôpital Militaire d´Instruction Mohamed V, Rabat, Maroc.
Doghmi K; Service d'Hématologie Clinique, Hôpital Militaire d´Instruction Mohamed V, Rabat, Maroc.
Pokaż więcej
Transliterated Title:
L’érythroblastopénie et la myélofibrose primitive: association très rare (à propos d’un cas).
Źródło:
The Pan African medical journal [Pan Afr Med J] 2022 Jul 13; Vol. 42, pp. 201. Date of Electronic Publication: 2022 Jul 13 (Print Publication: 2022).
Typ publikacji:
Case Reports; English Abstract
MeSH Terms:
Primary Myelofibrosis*/complications
Primary Myelofibrosis*/diagnosis
Primary Myelofibrosis*/therapy
Red-Cell Aplasia, Pure*
Humans ; Aged ; Splenomegaly/etiology ; Cyclosporine ; Spleen ; Bone Marrow/pathology ; Bone Marrow Failure Disorders
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Roxadustat Improves Erythropoietin Antibody-Mediated Pure Red Cell Aplasia in a Patient with Hemodialysis.
Autorzy:
Li S; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Chen X; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Hu P; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Wu S; Department of hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ma J; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Li Z; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Wu X; Department of Nephrology, Guangdong Armed Police Hospital, Guangzhou, China.
Wen F; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Fu X; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Feng Z; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Tao Y; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Li B; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Fu L; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Huang R; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
He C; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Shi W; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Liang X; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Liu S; Department of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Pokaż więcej
Źródło:
Blood purification [Blood Purif] 2022; Vol. 51 (2), pp. 189-192. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji:
Case Reports; Research Support, Non-U.S. Gov't
MeSH Terms:
Erythropoietin*/therapeutic use
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/etiology
Aged ; Glycine/analogs & derivatives ; Humans ; Isoquinolines ; Male ; Recombinant Proteins ; Renal Dialysis/adverse effects
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pure red cell aplasia secondary to rheumatoid arthritis: a case report.
Autorzy:
Weerasinghe S; Teaching Hospital, Peradeniya, Sri Lanka.
Karunathilake P; Department of Medicine, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka. .
Ralapanawa U; Department of Medicine, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka.
Jayalath T; Department of Medicine, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka.
Abeygunawardena S; Department of Medicine, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka.
Rathnayaka M; Department of Pathology, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2021 Dec 06; Vol. 15 (1), pp. 578. Date of Electronic Publication: 2021 Dec 06.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/drug therapy
Red-Cell Aplasia, Pure*/diagnosis
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/etiology
Thymoma*
Thymus Neoplasms*
Cyclosporine/therapeutic use ; Female ; Humans ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia.
Autorzy:
Wang H; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Niu H; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Zhang T; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Xing L; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Shao Z; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Fu R; Department of Hematology, General Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 444-446.
Typ publikacji:
Journal Article
MeSH Terms:
Myelodysplastic Syndromes/*complications
Red-Cell Aplasia, Pure/*complications
Aged ; Androgens/therapeutic use ; Cyclosporine/therapeutic use ; Erythropoietin/therapeutic use ; Female ; Glucocorticoids/therapeutic use ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Male ; Middle Aged ; Myelodysplastic Syndromes/diagnosis ; Myelodysplastic Syndromes/drug therapy ; Prognosis ; Red-Cell Aplasia, Pure/diagnosis ; Red-Cell Aplasia, Pure/drug therapy ; Retrospective Studies ; Sirolimus/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility.
Autorzy:
Crysandt M; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
Soysal H; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
Jennes E; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Holtick U; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.; Department I of Internal Medicine, Medical Faculty and University Hospital, University of Cologne, Cologne, Germany.
Mrotzek M; Institute of Transfusion Medicine, Medical Faculty and University Hospital, University of Cologne, Cologne, Germany.
Rehnelt S; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.; Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Holderried TAW; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.; Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Wessiepe M; Division of Transfusion Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Kunter U; Department of Nephrology and Clinical Immunology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Wilop S; MVZ West GmbH Würselen, Hämatologie-Onkologie, Würselen, Germany.
Silling G; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
Gecht J; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
Beier F; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
Jost E; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2021 Sep; Vol. 107 (3), pp. 324-332. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation/*methods
Leukemia/*therapy
Myelodysplastic Syndromes/*therapy
Myeloproliferative Disorders/*therapy
Plasmapheresis/*methods
Red-Cell Aplasia, Pure/*prevention & control
Transfusion Reaction/*prevention & control
ABO Blood-Group System/immunology ; Blood Group Incompatibility/immunology ; Blood Group Incompatibility/mortality ; Blood Group Incompatibility/therapy ; Erythrocyte Transfusion/adverse effects ; Female ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Leukemia/immunology ; Leukemia/mortality ; Male ; Middle Aged ; Myelodysplastic Syndromes/immunology ; Myelodysplastic Syndromes/mortality ; Myeloproliferative Disorders/immunology ; Myeloproliferative Disorders/mortality ; Red-Cell Aplasia, Pure/etiology ; Red-Cell Aplasia, Pure/immunology ; Red-Cell Aplasia, Pure/mortality ; Retrospective Studies ; Survival Analysis ; Tissue Donors ; Transfusion Reaction/etiology ; Transfusion Reaction/immunology ; Transfusion Reaction/mortality ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Caution the masker of Good's sydrome on the secondary pure red cell aplasia.
Autorzy:
Chen W; Department of Anesthesiology, Xinchang Hospital Affiliated to Wenzhou Medical University, Xinchang, People's Republic of China.
Jiang L; Department of Clinical Laboratory, Immunology & Hematology Unit, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, People's Republic of China.
Liu J; Department of Clinical Laboratory, Immunology & Hematology Unit, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2021 Dec; Vol. 26 (1), pp. 588-589.
Typ publikacji:
Letter; Comment
MeSH Terms:
Red-Cell Aplasia, Pure*/etiology
Thymoma*
Thymus Neoplasms*
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 10132

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies